Most linked-to pages

Showing below up to 246 results in range #1 to #246.

1. Main Page‏‎ (152 links)
2. Educational Materials‏‎ (81 links)
3. Diagnostic Kits‏‎ (78 links)
4. Biotechnology - Genomic and Proteomics‏‎ (40 links)
5. Alternative Energy‏‎ (37 links)
6. The K-12 Level‏‎ (22 links)
7. Contacts for EM‏‎ (20 links)
8. Overall Picture of the EM field‏‎ (20 links)
9. The Higher Education Level‏‎ (20 links)
10. Report April 2009‏‎ (19 links)
11. Bibliography for Item 2 in EM‏‎ (18 links)
12. Commons-based Cases in EM‏‎ (16 links)
13. Pearson‏‎ (15 links)
14. Alternative Energy/Bibliography by Research Question‏‎ (14 links)
15. Educational Materials/Bibliography by Research Question‏‎ (14 links)
16. IP Profile of Biggest for-profit companies in EM‏‎ (14 links)
17. Telecommunications‏‎ (14 links)
18. User:EGraeff‏‎ (12 links)
19. ICP Team‏‎ (12 links)
20. Bibliography for Item 6 in EM‏‎ (11 links)
21. McGraw-Hill‏‎ (10 links)
22. IP Profile of Biggest for-profit companies in EM-K12‏‎ (10 links)
23. Diagnostic Kits/Analysing DNA patents in relation with diagnostic genetic testing‏‎ (9 links)
24. Overall Picture of the EM-K12 field‏‎ (9 links)
25. ICP Reports and Working Papers‏‎ (9 links)
26. Diagnostic Kits/A pilot survey on the licensing of DNA inventions‏‎ (9 links)
27. Cengage Learning‏‎ (9 links)
28. Diagnostic Kits/The licensing of DNA patents by US academic institutions‏‎ (9 links)
29. Commons-based Cases in EM-K12‏‎ (9 links)
30. Alternative Business Models in EM‏‎ (9 links)
31. Diagnostic Kits/A clearing house for diagnostic testing: the solution to ensure access to and use of patented genetic inventions‏‎ (9 links)
32. Diagnostic Kits/Diagnostic Test Service Commercialization in Multiplex and Esoteric Testing‏‎ (8 links)
33. California‏‎ (8 links)
34. Diagnostic Kits/The Value of Diagnostics: Innovation, Adoption and Diffusion Into Health Care‏‎ (8 links)
35. IP Profile of Biggest for-profit companies in AE‏‎ (8 links)
36. ICP Parking Lot‏‎ (8 links)
37. Data, narratives and tools produced by the EM field‏‎ (8 links)
38. IP Profile of Universities working in EM‏‎ (8 links)
39. Textbooks‏‎ (8 links)
40. Diagnostic Kits/Diagnostic testing fails the test‏‎ (8 links)
41. Diagnostic Kits/DNA-based patents: an empirical analysis‏‎ (8 links)
42. IP Profile of non-profit companies in EM‏‎ (8 links)
43. User:WikiSysop‏‎ (8 links)
44. IP Profile of Associations in EM-K12‏‎ (7 links)
45. Data, narratives and tools produced by the EM-K12 field‏‎ (7 links)
46. Overview of Economics of Intellectual Property in EM‏‎ (7 links)
47. Bibliography for Item 3 in EM‏‎ (7 links)
48. Diagnostic Kits/DNA Patenting and Licensing‏‎ (7 links)
49. Diagnostic Kits/Disease Gene Patents‏‎ (7 links)
50. ICP Sectors‏‎ (7 links)
51. Diagnostic Kits/Glossary‏‎ (7 links)
52. Houghton Mifflin‏‎ (7 links)
53. Diagnostic Kits/Intellectual Property Landscape of the Human Genome‏‎ (7 links)
54. Industrial Cooperation Project‏‎ (7 links)
55. Diagnostic Kits/Models for facilitating access to patents on genetic inventions‏‎ (7 links)
56. Diagnostic Kits/Effects of patents and licenses on the provision of clinical genetic testing services‏‎ (7 links)
57. Diagnostic Kits/Patent pools and diagnostic testing‏‎ (7 links)
58. Give an overall picture of the AE field‏‎ (7 links)
59. IP in EM‏‎ (7 links)
60. Give an overall picture of the Kits' sector‏‎ (6 links)
61. IP Profile of Biggest for-profit companies in BGP‏‎ (6 links)
62. Diagnostic Kits/Case Law Review‏‎ (6 links)
63. Defining the Commons‏‎ (6 links)
64. Country AE Profiles‏‎ (6 links)
65. IP Profile of Universities working in Kits‏‎ (6 links)
66. Competitive advantages in EM‏‎ (6 links)
67. IP Profile of Associations in EM‏‎ (6 links)
68. Wiley‏‎ (6 links)
69. Diagnostic Kits/Country Reports Review‏‎ (6 links)
70. Alternative Business Models in EM-K12‏‎ (5 links)
71. Diagnostic Kits/USA Regulation Review‏‎ (5 links)
72. Competitive advantages in EM-K12‏‎ (5 links)
73. IP in EM-K12‏‎ (5 links)
74. IP Profile of Associations in AE‏‎ (5 links)
75. Data, narratives and tools produced by the Kits' sector‏‎ (5 links)
76. Diagnostic Kits/Bibliography‏‎ (5 links)
77. Overview of Economics of Intellectual Property in EM-K12‏‎ (5 links)
78. Commons based cases in AE‏‎ (5 links)
79. IP Profile of non-profit companies in AE‏‎ (5 links)
80. IP Profile of Universities working in EM-K12‏‎ (5 links)
81. Diagnostic Kits/Priorities for Personalized Medicine‏‎ (5 links)
82. Innovations in Wind, Solar and Tidal‏‎ (5 links)
83. Diagnostic Kits/Diagnosis or drug- Will pharmaceutical companies or diagnostics manufacturers earn more from personalized medicine‏‎ (5 links)
84. Erhardt Graeff‏‎ (5 links)
85. IP Profile of non-profit companies in EM-K12‏‎ (5 links)
86. Verlagsgruppe Georg von Holtzbrinck‏‎ (5 links)
87. IP in Kits‏‎ (5 links)
88. Field Research Methodology‏‎ (5 links)
89. Florida‏‎ (4 links)
90. Competitive advantages in Kits‏‎ (4 links)
91. Legislation on Policy Theme 6 for EM‏‎ (4 links)
92. SACGHS Appendix 1- Compendium of Case Studies on the Impact of Gene Patents and Licensing Practices on Access to Genetic Testing‏‎ (4 links)
93. Reed Elsevier‏‎ (4 links)
94. Bibliography for Item 1 in EM‏‎ (4 links)
95. IP Profile of Associations in Kits‏‎ (4 links)
96. Legislation on Policy Theme 7 for EM‏‎ (4 links)
97. Diagnostic Kits/The dangers of diagnostic monopolies‏‎ (4 links)
98. IP Profile of Biggest for-profit companies in Kits‏‎ (4 links)
99. Legislation on Policy Theme 8 for EM‏‎ (4 links)
100. Texas‏‎ (4 links)
101. IP Profile of Universities working in AE‏‎ (4 links)
102. Diagnostic Kits/Patents versus patenting: implications of intellectual property protection for biological research‏‎ (4 links)
103. Houghton Mifflin Harcourt‏‎ (4 links)
104. IP Profile of non-profit companies in Kits‏‎ (4 links)
105. Legislation on Policy Theme 1 for EM‏‎ (4 links)
106. Diagnostic Kits/SACGHS Gene Patents and Licensing Practices‏‎ (4 links)
107. Legislation on Policy Theme 9 for EM‏‎ (4 links)
108. Open Business models in Kits‏‎ (4 links)
109. Legislation on Policy Theme 2 for EM‏‎ (4 links)
110. Diagnostic Kits/Patents and the Progress of Personalized Medicine‏‎ (4 links)
111. IP in AE‏‎ (4 links)
112. Overview of Economics of Intellectual Property in Kits‏‎ (4 links)
113. Legislation on Policy Theme 3 for EM‏‎ (4 links)
114. Methodology‏‎ (4 links)
115. Diagnostic Kits/Clinically Available Pharmacogenomics Tests‏‎ (4 links)
116. Paper‏‎ (4 links)
117. Legislation on Policy Theme 4 for EM‏‎ (4 links)
118. Overview of Economics of Intellectual Property in AE‏‎ (4 links)
119. Commons based cases in Kits‏‎ (4 links)
120. Peer-Production Business models in Kits‏‎ (4 links)
121. Legislation on Policy Theme 5 for EM‏‎ (4 links)
122. ICP Main Questions‏‎ (4 links)
123. Bill Hughes Interview Notes - October 7, 2009‏‎ (3 links)
124. Peter Levy Interview Notes - September 18, 2009‏‎ (3 links)
125. Bibliography for Item 11 in EM‏‎ (3 links)
126. Bibliography for Item 8 in EM‏‎ (3 links)
127. Diagnostic Kits/Bibliography by Resource Type‏‎ (3 links)
128. Diagnostic Kits/Legal uncertainty in the area of genetic diagnostic testing‏‎ (3 links)
129. Vaccines‏‎ (3 links)
130. Bibliography for Item 2 in BGP‏‎ (3 links)
131. Bobbi Kurshan Interview Notes - August 17, 2009‏‎ (3 links)
132. Bibliography for Item 9 in EM‏‎ (3 links)
133. Diagnostic Kits/Commons based cases in Kits‏‎ (3 links)
134. Commons based cases in BGP‏‎ (3 links)
135. IP Profile of Universities working in BGP‏‎ (3 links)
136. Cathy Swift Interview Notes - September 21, 2009‏‎ (3 links)
137. Harcourt Education‏‎ (3 links)
138. Andrew Clearwater‏‎ (3 links)
139. Diagnostic Kits/The Search for Alternatives to Patents in the 21st Century‏‎ (3 links)
140. Jonathan Emmons Interview Notes‏‎ (3 links)
141. Alternative Energy/Paper‏‎ (3 links)
142. Diagnostic Kits/Diagnostic Test Service Commercialization- A Roadmap to Diagnostics in the 21st Century‏‎ (3 links)
143. Competitive advantages in BGP‏‎ (3 links)
144. IP Profile of non-profit companies in BGP‏‎ (3 links)
145. United States Country Report (Diagnostic Kits)‏‎ (3 links)
146. Report September 2009‏‎ (3 links)
147. Diagnostic Kits/Diagnostics and biomarker development- priming the pipeline‏‎ (3 links)
148. Diagnostic Kits/SACGHS Gene Patents and Licensing Practices Final Report‏‎ (3 links)
149. IP in BGP‏‎ (3 links)
150. Bibliography for Item 7 in AE‏‎ (3 links)
151. Ahrash Bissell Interview Notes - July 20, 2009‏‎ (3 links)
152. Hal Plotkin Interview Notes - August 10, 2009‏‎ (3 links)
153. Bibliography for Item 4 in EM‏‎ (3 links)
154. Diagnostic Kits/SACGHS U.S. System of Oversight of Genetic Testing‏‎ (3 links)
155. History of EM Field‏‎ (3 links)
156. Open Business models in BGP‏‎ (3 links)
157. BGP Table of Biggest For-Profit Companies‏‎ (3 links)
158. Ahrash Bissell Interview Notes - May 12, 2009‏‎ (3 links)
159. Joel Thierstein Interview Notes - August 19, 2009‏‎ (3 links)
160. Bibliography for Item 5 in EM‏‎ (3 links)
161. Economics of Intellectual Property‏‎ (3 links)
162. Diagnostic Kits/Testing new ground‏‎ (3 links)
163. Give an overall picture of the BGP field‏‎ (3 links)
164. Overview of Economics of Intellectual Property in BGP‏‎ (3 links)
165. Anne Schreiber Interview Notes - August 27, 2009‏‎ (3 links)
166. AE Essay on EFRC Survey‏‎ (3 links)
167. Kathi Fletcher Interview Notes - August 26, 2009‏‎ (3 links)
168. Ahrash Bissell Interview Notes‏‎ (3 links)
169. All Bibliographic Sources‏‎ (3 links)
170. Diagnostic Kits/Interviews‏‎ (3 links)
171. Diagnostic Kits/Bibliography by Research Question‏‎ (3 links)
172. Bibliography for Item 2 in AE‏‎ (3 links)
173. Neeru Khosla Interview Notes - September 4, 2009‏‎ (3 links)
174. Bibliography for Item 10 in EM‏‎ (3 links)
175. Bibliography for Item 7 in EM‏‎ (3 links)
176. Brendan Ballou‏‎ (3 links)
177. IP Profile of Associations in BGP‏‎ (3 links)
178. Sage - A Merck Project‏‎ (3 links)
179. Jeremy M. Firestone‏‎ (2 links)
180. User:Mac/The Problems of Patents on Diagnostic Testing Kits‏‎ (2 links)
181. Data, narratives and tools produced by the Kits' sector/GeneDxChart‏‎ (2 links)
182. Diagnostic Kits/Biotechnology and Intellectual Property Reinventing the Commons‏‎ (2 links)
183. Diagnostic Kits/Patents and translational research in genomics‏‎ (2 links)
184. Biotechnology - Genomic and Proteomics/Others‏‎ (2 links)
185. Biotechnology - Genomic and Proteomics/Give an overall picture of the BGP field‏‎ (2 links)
186. Introduction to Telecommunications Industries‏‎ (2 links)
187. Bibliography for Item 11 in BGP‏‎ (2 links)
188. ICP Complete Bibliography‏‎ (2 links)
189. Interviews for Blog‏‎ (2 links)
190. Meeting Fellow + RAs‏‎ (2 links)
191. Silas Bauer‏‎ (2 links)
192. Alternative Energy/Bibliography by Resource Type‏‎ (2 links)
193. Diagnostic Kits/Patents limit medical potential of sequencing‏‎ (2 links)
194. Educational Materials/Bibliography by Resource Type‏‎ (2 links)
195. Template:Xpd‏‎ (2 links)
196. Bibliography for Item 4 in AE‏‎ (2 links)
197. Bibliography for Item 6 in BGP‏‎ (2 links)
198. E-Book Readers‏‎ (2 links)
199. Biotechnology - Genomic and Proteomics/Data, narratives and tools produced by the BGP field‏‎ (2 links)
200. Walt Musial‏‎ (2 links)
201. User:Mac/Research Question‏‎ (2 links)
202. Diagnostic Kits/Secretary's Advisory Committee on Genetics‏‎ (2 links)
203. Meeting ICP + OCP‏‎ (2 links)
204. Educational Materials/Interviews‏‎ (2 links)
205. W:Wikipedia:Template documentation‏‎ (2 links)
206. Biotechnology - Genomic and Proteomics/IP in BGP‏‎ (2 links)
207. Eric Frank Interview Notes - October 22, 2009‏‎ (2 links)
208. History of US Textbook Publishing‏‎ (2 links)
209. Data, narratives and tools produced by the BGP field‏‎ (2 links)
210. Bibliography for Item 7 in BGP‏‎ (2 links)
211. Biotechnology - Genomic and Proteomics/Competitive advantages in BGP‏‎ (2 links)
212. Lessons from ANT‏‎ (2 links)
213. Diagnostic Kits/Give an overall picture of the Kits' sector‏‎ (2 links)
214. Meeting with Yochai‏‎ (2 links)
215. Competitive advantages in AE‏‎ (2 links)
216. Diagnostic Kits/Direct-to-consumer genetic testing- two sides of the coin‏‎ (2 links)
217. Bibliography for Item 8 in BGP‏‎ (2 links)
218. Bibliography for Item 12 in BGP‏‎ (2 links)
219. Posts for ICP Blog‏‎ (2 links)
220. Diagnostic Kits/Morrison and Foerster Represents ACON Laboratories in $175 Million Acquisition by Inverness Medical Innovations‏‎ (2 links)
221. Bibliography for Item 3 in BGP‏‎ (2 links)
222. Bibliography for Item 9 in BGP‏‎ (2 links)
223. Report May 2009‏‎ (2 links)
224. User:Mac/Interviews‏‎ (2 links)
225. Blogs to watch on EM‏‎ (2 links)
226. Jonathan Emmons Interview Notes - March 25, 2009‏‎ (2 links)
227. Michael Steffen‏‎ (2 links)
228. Diagnostic Kits/Genes and ingenuity: gene patenting and human health report‏‎ (2 links)
229. Diagnostic Kits/NIH Principles and Guidelines for Sharing of Biomedical Resources‏‎ (2 links)
230. Diagnostic Kits/The market economy, and the scientific commons‏‎ (2 links)
231. Bibliography for Item 4 in BGP‏‎ (2 links)
232. Government in BGP‏‎ (2 links)
233. Peer-Production Business models in BGP‏‎ (2 links)
234. Anne Schreiber Interview Notes - August 31, 2009‏‎ (2 links)
235. ICP Parking Lot/Sustainability‏‎ (2 links)
236. Diagnostic Kits/USA Regulation‏‎ (2 links)
237. Diagnostic Kits/The Argument Framework‏‎ (2 links)
238. Links on EM‏‎ (2 links)
239. Questionnaire for Case Studies‏‎ (2 links)
240. Diagnostic Kits/Nonenforcement, Noneproblem Rethinking the Anticommons in Biomedical Research‏‎ (2 links)
241. Biotechnology - Genomic and Proteomics/Bibliography by Research Question‏‎ (2 links)
242. Bibliography for Item 3 in AE‏‎ (2 links)
243. Bibliography for Item 1 in BGP‏‎ (2 links)
244. Bibliography for Item 5 in BGP‏‎ (2 links)
245. Bibliography for Item 10 in BGP‏‎ (2 links)
246. Biotechnology - Genomic and Proteomics/Overview of Economics of Intellectual Property in BGP‏‎ (2 links)